Asset Details
Do you wish to reserve the book?
Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
Do you wish to request the book?
Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
2020
Overview
Gene and cell therapy products approved over the past decade in Europe and North America have provided new therapeutic options for single gene disorders and for hematologic malignancies. Lessons learned, and limitations identified, are reviewed.
